DIFFERENTIATION OF AUTOIMMUNE OPHTHALMOPATHY FROM GRAVES’HYPERTHYROIDISM BY ANALYSIS OF GENETIC MARKERS

Graves' hyperthyroidism and dysthyroid eye disease are closely related autoimmune conditions. Whether the eye disease is an integral part of Graves' disease or a separate entity is controversial. To investigate this we have examined the genetic associations of ophthalmopathy and hyperthyroidism, and compared their phenotype and gene frequencies with a control normal population. HLA‐A, B, and DR antigens were typed in 67 patients with dysthyroid eye disease (GO), 60 hyperthyroid patients without significant eye disease (HT) and 500 normal subjects. Patients were also typed for a variety of other genetic markers: blood group systems (10), serum proteins (6) and red cell enzyme systems (10). Increased frequency of B8 and DR3 in Graves' disease was confirmed; B17 occurred less frequently and appears to be protective. HLA antigen frequencies for GO did not differ from HT. The MNS blood group showed a significant association with Graves' disease, the HT patients having a deficit of the s gene compared with controls. The most interesting finding was an increased frequency of blood group P in GO patients compared with either HT or controls. Significant differences were not seen with any of the other HLA antigens, blood groups, protein or enzyme markers considered individually. Multivariate analysis applied first to the HLA and then to the non‐HLA systems indicated clear separation of the two patient groups. Although Graves' eye disease shares the same HLA associations as hyperthyroidism, it differs in the increased frequency of P blood group, suggesting that additional genetic factors may determine which patients with Graves' disease develop ophthalmopathy.

[1]  J. Rock,et al.  The association of anti‐P and early abortion , 1987, Transfusion.

[2]  R. Fauchet,et al.  HLA immunogenetic heterogeneity in black American patients with Graves' disease. , 1987, Archives of internal medicine.

[3]  N. Farid,et al.  GENETIC FACTORS IN GRAVES' OPHTHALMOPATHY , 1986, Clinical endocrinology.

[4]  J. Lanchbury,et al.  Genetic structure of the population with rheumatoid arthritis in north east England: a genetic approach to define different subtypes. , 1986, Annals of the rheumatic diseases.

[5]  C. Rotella,et al.  Ability of monoclonal antibodies to the thyrotropin receptor to increase collagen synthesis in human fibroblasts: an assay which appears to measure exophthalmogenic immunoglobulins in Graves' sera. , 1986, The Journal of clinical endocrinology and metabolism.

[6]  P. Kendall‐Taylor 2 The pathogenesis of graves' ophthalmopathy , 1985 .

[7]  N. Farid,et al.  IDENTIFICATION OF SUBSETS OF PATIENTS WITH GRAVES’DISEASE BY CLUSTER ANALYSIS , 1983, Clinical endocrinology.

[8]  W. Mayr,et al.  HLA-DR3 and HLA-DR5 associated thyrotoxicosis--two different types of toxic diffuse goiter. , 1983, The Journal of clinical endocrinology and metabolism.

[9]  R. J. Mitchell,et al.  Genetic structure in Cumbria , 1981, Journal of Biosocial Science.

[10]  N. Farid,et al.  The human major histocompatibility complex and endocrine disease. , 1981, Endocrine reviews.

[11]  C. Gorman The presentation and management of endocrine ophthalmopathy. , 1978, Clinics in endocrinology and metabolism.

[12]  J. Nerup,et al.  HLA antigens in Graves' disease. , 1977, Acta endocrinologica.

[13]  W. Mayr,et al.  Genetic heterogeneity in thyrotoxicosis patients with and without endocrine ophthalmopathy. , 1977, Diabete & metabolisme.

[14]  D. Evered,et al.  THYROID‐STIMULATING IMMUNOGLOBULINS IN OPHTHALMIC GRAVES'DISEASE , 1977, Clinical endocrinology.

[15]  D. N. Raine,et al.  Handbook of Enzyme Electrophoresis in Human Genetics , 1977 .

[16]  D. Solomon,et al.  Identification of subgroups of euthyroid graves's ophthalmopathy. , 1977, The New England journal of medicine.

[17]  W. Mayr,et al.  HLA CW3 in thyrotoxicosis patients with and without endocrine ophthalmopathy. , 2008, Tissue antigens.

[18]  J. Nam,et al.  Bernstein's and gene‐counting methods in generalized ABO‐like systems , 1976, Annals of human genetics.

[19]  J. Konishi,et al.  HL-A antigens as markers for disease susceptibility and autoimmunity in Graves' disease. , 1974, The Journal of clinical endocrinology and metabolism.

[20]  J. Dausset,et al.  Studies on the Biosynthetic Pathway of Human P Erythrocyte Antigens Using Somatic Cells in Culture , 1974, Vox sanguinis.

[21]  J. Sisson,et al.  The effects of lymphocytes, sera, and long-acting thyroid stimulator from patients with Graves' disease on retrobulbar fibroblasts. , 1973, The Journal of clinical endocrinology and metabolism.

[22]  S C Werner,et al.  Classification of the eye changes of Graves' disease. , 1969, American journal of ophthalmology.

[23]  C. Alper,et al.  Genetic polymorphism of the third component of human complement (C'3). , 1968, The Journal of clinical investigation.

[24]  G. Leigheb,et al.  SURVIVAL OF TEST SKIN GRAFTS IN MAN: EFFECT OF GENETIC RELATIONSHIP AND OF BLOOD GROUPS INCOMPATIBILITY * , 1966 .

[25]  O. Smithies,et al.  Zone electrophoresis in starch gels: group variations in the serum proteins of normal human adults. , 1955, The Biochemical journal.